New hope for scleroderma: experimental drug CM-101 enters Mid-Stage trial
Disease control
Terminated
This study tests an experimental drug called CM-101 in people with systemic sclerosis (scleroderma), a rare disease that causes hardening and tightening of the skin and can damage internal organs. About 45 adults will receive either the drug or a placebo to check if it is safe an…
Phase: PHASE2 • Sponsor: ChemomAb Ltd. • Aim: Disease control
Last updated May 06, 2026 19:01 UTC